10 - 12 June, 2025
Congress CenterBasel SwitzerlandDr. Gregory Brittingham, PhDDirector of Product at NeochromosomeSpeaker
Profile
Greg Brittingham, Ph.D. is the Director of Product at Neochromosome, where he leads research and commercialization of innovative platform technologies based on Neochromosome’s genome-scale cell engineering technology stack. Greg received his Ph.D. from New York University, where he studied cell biology and computational biology. He discovered that changes in molecular crowding downstream of mTOR signaling can drastically alter cell behavior and biophysics.
Agenda Sessions
Neochromosome’s Antibody ToolkitTM: How a ‘Switchable’ Yeast, Antibody Libraries and Laboratory Robotics Enable High Throughput Hit Characterization
, 12:20View Session